Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination

American Journal of Pathology

Volumn 174, Issue 2, 2009, Pages 371-379

  Smith, Steven Christopher ^a   Nicholson, Brian ^a   Nitz, Matthew ^a   Frierson Jr , Henry F ^b   Smolkin, Mark ^b   Hampton, Garret ^c   El Rifai, Wael ^b   Theodorescu, Dan ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ 5 GAMMA 2; ONCOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER STAGING; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE MARKER; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN ANALYSIS; TRANSCRIPTOMICS;

EID: 59649113022     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080538     Document Type: Article

References (35)

1. Steeg PS, Theodorescu D: Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 2008, 5:206-219
2. Horak CE, Steeg PS: Metastasis gets site specific. Cancer Cell 2005, 8:93-95
3. Gupta GP, Massague J: Cancer metastasis: building a framework. Cell 2006, 127:679-695
4. Fidler IJ: Selection of successive tumour lines for metastasis. Nat New Biol 1973, 242:148-149
5. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549
6. Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massague J: Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 2005, 115:44-55
7. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J: Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524
8. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 2005, 55:10-30
9. Wu XR: Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005, 5:713-725
10. Gildea JJ, Golden WL, Harding MA, Theodorescu D: Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer. Genes Chromosom Cancer 2000, 27:252-263
11. Gildea JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA, Frierson HF, Conaway MR, Theodorescu D: RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 2002, 62:6418-6423
12. Harding MA, Arden KC, Gildea JW, Gildea JJ, Perlman EJ, Viars C, Theodorescu D: Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. Cancer Res 2002, 62:6981-6989
13. Nicholson BE, Frierson HF, Conaway MR, Seraj JM, Harding MA, Hampton GM, Theodorescu D: Profiling the evolution of human metastatic bladder cancer. Cancer Res 2004, 64:7813-7821
14. Gildea JJ, Herlevsen M, Harding MA, Gulding KM, Moskaluk CA, Frierson HF, Theodorescu D: PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Oncogene 2004, 23:6788-6797
15. Wu Z, Siadaty MS, Riddick G, Frierson Jr HF, Lee JK, Golden W, Knuutila S, Hampton GM, El-Rifai W, Theodorescu D: A novel method for gene expression mapping of metastatic competence in human bladder cancer. Neoplasia 2006, 8:181-189
16. Smith SC, Oxford G, Wu Z, Nitz MD, Conaway M, Frierson HF, Hampton G, Theodorescu D: The metastasis-associated gene CD24 is regulated by ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res 2006, 66:1917-1922
17. Smith SC, Oxford G, Baras AS, Owens C, Havaleshko D, Brautigan DL, Safo MK, Theodorescu D: Expression of ral GTPases, their effectors, and activators in human bladder cancer. Clin Cancer Res 2007, 13:3803-3813
18. Kiyoshima K, Oda Y, Kinukawa N, Naito S, Tsuneyoshi M: Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2. Hum Pathol 2005, 36:522-530
19. Koshikawa N, Minegishi T, Sharabi A, Quaranta V, Seiki M: Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain. J Biol Chem 2005, 280:88-93
20. Algaba F: Lymphovascular invasion as a prognostic tool for advanced bladder cancer. Curr Opin Urol 2006, 16:367-371
21. Pelkey TJ, Frierson Jr HF, Bruns DE: Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 1996, 42:1369-1381
22. Weinberg RA: Leaving home early: reexamination of the canonical models of tumor progression. Cancer Cell 2008, 14:283-284
23. Lucke B, Breedis C, Woo ZP, Berwick L, Nowell P: Differential growth of metastatic tumors in liver and lung; experiments with rabbit V2 carcinoma. Cancer Res 1952, 12:734-738
24. Harun N, Nikfarjam M, Muralidharan V, Christophi C: Liver regeneration stimulates tumor metastases. J Surg Res 2007, 138:284-290
25. Christophi C, Harun N, Fifis T: Liver regeneration and tumor stimulation - a review of cytokine and angiogenic factors. J Gastrointest Surg 2008, 12:966-980
26. Paget S: The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989, 8:98-101
27. Nash KT, Phadke PA, Navenot JM, Hurst DR, Accavitti-Loper MA, Sztul E, Vaidya KS, Frost AR, Kappes JC, Peiper SC, Welch DR: Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. J Natl Cancer Inst 2007, 99:309-321
28. Qin LX: Chromosomal aberrations related to metastasis of human solid tumors. World J Gastroenterol 2002, 8:769-776
29. Jiang JK, Chen YJ, Lin CH, Yu IT, Lin JK: Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases-an analysis by comparative genomic hybridization. Genes Chromosom Cancer 2005, 43:25-36
30. Knösel T, Schluns K, Dietel M, Petersen I: Chromosomal alterations in lung metastases of colorectal carcinomas: associations with tissue specific tumor dissemination. Clin Exp Metastasis 2005, 22:533-538
31. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007, 104:10158-10163
32. Baeuerle PA, Gires O: EpCAM (CD326) finding its role in cancer. Br J Cancer 2007, 96:1491
33. Brunner A, Prelog M, Verdorfer I, Tzankov A, Mikuz G, Ensinger C: EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinomas of the bladder. J Clin Pathol 2008, 61:307-310
34. Titus B, Frierson Jr HF, Conaway M, Ching K, Guise T, Chirgwin J, Hampton G, Theodorescu D: Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. Cancer Res 2005, 65:7320-7327
35. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988